0 followers
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Stephen J. Russell
Kura Oncology
18 followers
Adverum Biotech
8 followers
SpringWorks Therapeutics
5 followers
Owkin
4 followers
Summit Therapeutics
4 followers
Prime Medicine
3 followers
CytomX
3 followers
Celldex Therapeutics
2 followers
Viridian Therapeutics
2 followers
Modern Meadow
2 followers
Vividion Therapeutics
1 follower
Explore companies